Trending Assets
Top investors this month
Trending Assets
Top investors this month
Bought 54% more NVCR
NovoCure at $44.97

Nathan Worden's avatar
Are you thinking the market is overreacting to the LUNAR study? Seemed like the results weren’t that bad. Just that the standard of care changed while the study was occurring.
Tim Noteboom's avatar
$13.2MFollowers
Related
Already have an account?